Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease

Bibliographic Details
Main Authors: Vargas, Ana Beatriz, Trope, Beatriz M, Bica, Blanca ERG
Format: Online
Language:English
Published: BioMed Central 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402938/
id pubmed-3402938
recordtype oai_dc
spelling pubmed-34029382012-07-25 Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease Vargas, Ana Beatriz Trope, Beatriz M Bica, Blanca ERG Poster Presentation BioMed Central 2012-07-13 /pmc/articles/PMC3402938/ http://dx.doi.org/10.1186/1546-0096-10-S1-A95 Text en Copyright ©2012 Vargas et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Vargas, Ana Beatriz
Trope, Beatriz M
Bica, Blanca ERG
spellingShingle Vargas, Ana Beatriz
Trope, Beatriz M
Bica, Blanca ERG
Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
author_facet Vargas, Ana Beatriz
Trope, Beatriz M
Bica, Blanca ERG
author_sort Vargas, Ana Beatriz
title Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
title_short Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
title_full Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
title_fullStr Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
title_full_unstemmed Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
title_sort tocilizumab for refractory castleman’s disease with paraneoplastic pemphigus and behçet’s disease
description
publisher BioMed Central
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402938/
_version_ 1611544845809090560